• Autonomous A2Z

  Participated · Equity · Mar 2026

  Autonomous A2Z develops autonomous vehicle technologies with a hybrid engineering approach that combines rule-based algorithms and AI-driven decision systems aimed at achieving Level 4 autonomy. The company operates a research center in Pyeongchon, Gyeonggi, and runs autonomous mobility projects in markets including Singapore (in partnership with Grab), the United Arab Emirates, and Japan, where it has begun robotaxi trials. It has accumulated total funding of 122.5 billion won following the recent 40.5 billion won pre-IPO round and is preparing for a Kosdaq listing. Planned uses of capital include expanding domestic and international projects and procuring sensors, controllers, and vehicle components. Autonomous A2Z is preparing to participate in a large-scale pilot program led by the South Korea Ministry of Transport. The company says it aims to accelerate commercial deployment of Level 4 driverless vehicles and to build a global data network to support that goal.

• AIMMO

  Participated · Equity · Sep 2023

  AIMMO offers AD-DaaS, a flagship solution that supplies optimized datasets tailored for autonomous driving by analyzing Operational Design Domains and curating scenario-specific data with expert annotation. Its services are designed to improve AI algorithm performance while reducing client development time and cost. AIMMO counts global OEMs and Tier 1 suppliers such as BOSCH, Continental, Magna International, and Tata Motors among its customers. The company is expanding beyond autonomous driving, exploring collaborations in smart city construction. Management says it has signed supply contracts across Europe, North America, and Japan and is driving projects in those regions. AIMMO plans to refine AD-DaaS, develop edge devices for data collection, and finalize full-cycle AI data solutions as part of its growth strategy. AIMMO builds an AI data-annotation platform and three annotation products: AIMMO DaaS for sensor-fusion/autonomous vehicle data, AIMMO GtaaS (turnkey big-data labeling) and AIMMO Enterprises, a web-based SaaS labeling tool. The company serves smart city, autonomous driving, robotics, OCR, smart factory, surveillance, e-commerce and logistics customers, including Hyundai Motor, Hyundai Mobis, Kakao Mobility, SoCar, ThoreDrive, SK Telecom, Naver and Kakao. AIMMO reported $10 million in revenue in 2021 and said sales and labeling volume through its DaaS platform grew 200% in 2021 versus 2020. The startup has about 200 employees and more than 10,000 data labelers globally. Headquartered in Korea, AIMMO has offices in the U.K., the U.S., Japan and Vietnam and plans to open offices in Germany and Canada in 2022. It competes with companies such as Scale AI, Playment, Understand.ai and Deepen AI as it pursues further global expansion.

• RIDI

  Participated · Equity · Feb 2022

  RIDI Corporation is South Korea’s largest digital content publication and distribution company, known for revitalizing the Korean e-book industry and supporting web novels, webcomics, animation, articles and news media. The company operates Manta, a global webcomics subscription service cited for its growth potential. RIDI was recently recognized as the first unicorn in Korea’s content platform industry with an enterprise value of KRW 1.6 trillion following a KRW 120 billion investment. With the new capital, RIDI plans to strengthen its global expansion and enhance competitiveness. The company will invest in original content and actively build a content value chain comprising webnovels, webcomics, videos, and OSTs by leveraging its key IPs. CEO Kisik Bae said the financing both validates RIDI’s competitiveness and secures partners to help expand its business globally beyond Korea.

• Deargen

  Participated · Series B · Feb 2022

  Deargen develops an end-to-end AI new drug development platform called Dr.UG that supports target discovery, substance design, synthesis, and drug development. The company says its platform enabled discovery of a first-in-class target for triple-negative breast cancer, design and synthesis of a new drug candidate, and a patent filing in ten weeks. Deargen has conducted partnerships with SK Chemical, Handok, Samsung Medical Center and established a U.S. branch in August last year to advance overseas collaboration. It has presented papers on AI-driven drug development at global conferences (AAAI, ACM, MLHC) and was named among the top 33 AI new drug discovery companies by Deep Pharma Intelligence. The Series B raise will fund creation of the iDear Center for AI-driven Drug Discovery and Development and expansion of Dr.UG applications. The iDear Center is intended to combine Deargen's AI technology with professionals who have over 20 years of new drug development experience to continually produce and verify AI-designed drug candidates.

• Riiid

  Participated · Series D · Jul 2020

  Riiid develops AI-powered personalized learning and test-prep applications, anchored by its Santa app for TOEIC preparation. The company says Santa has been used by more than 2.5 million students in Korea and Japan and has expanded via partnerships for GMAT (with Kaplan), ACT prep (with ConnecME Education) and college-entrance exam tools in Latin America. Riiid also builds vocational education apps, including Santa Realtor for real estate exam prep and a tool for insurance agent exams. The company emphasizes R&D and IP: it has applied for 103 domestic and international patents and had 27 issued. Riiid plans to use new funding to expand its product line and grow its international footprint. Riiid builds AI education solutions centered on Santa, a mobile test-prep application for the TOEIC exam that has been used by more than a million students in Korea and Japan and reached No.1 in sales among education apps in both countries. Its proprietary AI analyzes student data and content, predicts scores and user behavior, and recommends personalized study plans in real time. The company is shifting to provide back-end solutions for companies, school districts and education ministries across a wider set of learning applications. The new funding will be used to advance its deep learning technology and to develop a formative learning support solution focused on continuous evaluation and feedback across the learning process. Riiid plans to accelerate global expansion across the U.S., South America, the Middle East and beyond. The company launched EdNet, an open AI-education database, in early 2020 and has applied for 70 patents (17 registered); it was established in 2014 and is based in Seoul. Riiid develops AI tutor solutions under the SantaInside platform and offers them as B2B products. Its SantaTOEIC service, launched in 2017, uses machine learning and deep learning to predict answer-choice probabilities and deliver 1:1 personalized curricula; the service has accumulated about 900,000 members. The company’s R&D team includes more than 30 math and computer-science masters and PhDs from institutions such as UC Berkeley, Yale, Seoul National University, KAIST, POSTECH, Korea University, and Hanyang University. Riiid has published AI research at the NeurIPS conference (a domestic first) and holds or has filed 41 patents across Korea, the U.S., China, and Japan. The firm plans to use new funding for aggressive R&D and to further develop and commercialize SantaInside across additional exam areas (SAT, civil-service exams) and to expand internationally. Financial specifics beyond the recent round size were not disclosed in the article.

No current team members are available.